These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17057914)

  • 1. Effect of thyroid hormones on cardiovascular and muscle systems and on exercise tolerance: a brief review.
    Gonçalves A; Resende ES; Fernandes ML; da Costa AM
    Arq Bras Cardiol; 2006 Sep; 87(3):e45-7. PubMed ID: 17057914
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid disease and the cardiovascular system.
    Danzi S; Klein I
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):517-28. PubMed ID: 24891175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-carnitine on thyroid hormone metabolism and on physical exercise tolerance.
    Benvenga S
    Horm Metab Res; 2005 Sep; 37(9):566-71. PubMed ID: 16175496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, metabolic, and organ-specific indices of thyroid function.
    Klein I
    Endocrinol Metab Clin North Am; 2001 Jun; 30(2):415-27, ix. PubMed ID: 11444169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. Might an imbalance between energy supplies and demands curtail incremental exercise in Gold stage I COPD patients?
    Scano GL
    J Appl Physiol (1985); 2008 Aug; 105(2):759. PubMed ID: 18678627
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid hormone and blood pressure regulation.
    Danzi S; Klein I
    Curr Hypertens Rep; 2003 Dec; 5(6):513-20. PubMed ID: 14594573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles.
    Aliverti A; Macklem PT
    J Appl Physiol (1985); 2008 Aug; 105(2):749-51; discussion 755-7. PubMed ID: 18678622
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular hemodynamics and exercise tolerance in thyroid disease.
    Kahaly GJ; Kampmann C; Mohr-Kahaly S
    Thyroid; 2002 Jun; 12(6):473-81. PubMed ID: 12165109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Debigaré R; Maltais F
    J Appl Physiol (1985); 2008 Aug; 105(2):764. PubMed ID: 18678630
    [No Abstract]   [Full Text] [Related]  

  • 10. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Aliverti A; Macklem PT
    J Appl Physiol (1985); 2008 Aug; 105(2):763. PubMed ID: 18678629
    [No Abstract]   [Full Text] [Related]  

  • 11. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    O'Donnell D; Webb K
    J Appl Physiol (1985); 2008 Aug; 105(2):765. PubMed ID: 18678631
    [No Abstract]   [Full Text] [Related]  

  • 12. Rehabilitation management of neuromuscular disease: the role of exercise training.
    Abresch RT; Han JJ; Carter GT
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):7-21. PubMed ID: 19730017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid status and exercise tolerance. Cardiovascular and metabolic considerations.
    McAllister RM; Delp MD; Laughlin MH
    Sports Med; 1995 Sep; 20(3):189-98. PubMed ID: 8571001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-energetic and cardio-pulmonary determinants of exercise tolerance in humans: Muscle-energetic and cardio-pulmonary determinants of exercise tolerance in humans.
    Ward SA
    Exp Physiol; 2007 Mar; 92(2):321-2. PubMed ID: 17360933
    [No Abstract]   [Full Text] [Related]  

  • 15. Actual trends in thyroid physiopathology.
    Horm Res; 1987; 26(1-4):1-230. PubMed ID: 3596464
    [No Abstract]   [Full Text] [Related]  

  • 16. The renal manifestations of thyroid disease.
    Mariani LH; Berns JS
    J Am Soc Nephrol; 2012 Jan; 23(1):22-6. PubMed ID: 22021708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid hormones: their role in the metabolism and mechanisms of secretion].
    Szybiński Z
    Przegl Lek; 1974; 31(0):suppl:30-3. PubMed ID: 4411284
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperthyroidism, the cardiovascular apparatus and physical exercise].
    Mercuro G; Martino E; Cherchi A
    Cardiologia; 1994 Sep; 39(9):657-62. PubMed ID: 7532105
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid hormones in the neonate: an overview of physiology and clinical correlation.
    Schmaltz C
    Adv Neonatal Care; 2012 Aug; 12(4):217-22. PubMed ID: 22864001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise physiology and testing in adult patients with congenital heart disease.
    Buber J; Rhodes J
    Heart Fail Clin; 2014 Jan; 10(1):23-33. PubMed ID: 24275292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.